Free Subscription

  • Access daily briefings and unlimited news articles

Premium

Try one month for $34.95
  • Quarterly magazine and digital
  • Indepth executive interviews
  • Unlimited news and insights
  • Expert opinion and analysis
×

Vaxine

Vaxine Archives

EpiVax receives funding for H7N9 vaccine trial

Immunology company wins $600,000 grant to create new vaccine for avian influenza virus.